Terminated PHASE4 INTERVENTIONAL 3-arm NCT01457820

Allopurinol in Acute Coronary Syndrome (ALLACS)

Allopurinol as a Possible New Therapy for Acute Coronary Syndromes:The Next Steps

Sponsor: British Heart Foundation

Updated 5 times since 2017 Last updated: May 26, 2015 Started: Apr 30, 2012 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow recruitment: stopped early

Other terminated trials from British Heart Foundation

See all terminations from British Heart Foundation

This PHASE4 trial investigates Chronic Stable Angina and is currently terminated or withdrawn. British Heart Foundation leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

British Heart Foundation
Stephen McSwiggan

Data source: University of Dundee

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dundee, United Kingdom